Membrane fusogenic nanoparticle‐based HLA‐peptide‐addressing universal T cell receptor‐engineered T (HAUL TCR‐T) cell therapy in solid tumor

por Xu, Ruihan, Wang, Qin, Zhu, Junmeng, Bei, Yuncheng, Chu, Yanhong, Sun, Zhichen, Du, Shiyao, Zhou, Shujuan, Ding, Naiqing, Meng, Fanyan, Liu, Baorui
Publicado 2023

Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy

por Sun, Zhichen, Chu, Yanhong, Xiao, Jie, Yang, Yueling, Meng, Fanyan, Wang, Xinyue, Dong, Yanbing, Zhu, Junmeng, Wu, Yirong, Qin, Lanqun, Ke, Yaohua, Liu, Baorui, Liu, Qin
Publicado 2023

Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy

por Zhu, Junmeng, Ke, Yaohua, Liu, Qin, Yang, Ju, Liu, Fangcen, Xu, Ruihan, Zhou, Hang, Chen, Aoxing, Xiao, Jie, Meng, Fanyan, Yu, Lixia, Li, Rutian, Wei, Jia, Liu, Baorui
Publicado 2022